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The complement system, typically associated with innate immunity, is emerging as a key controller of nonimmune systems including in
development, with recent studies linking complement mutations with neurodevelopmental disease. A key effector of the complement
response is the activation fragmentC5a,which, through its receptorC5aR1, is a potent driver of inflammation. Surprisingly, C5aR1 is also
expressed during early mammalian embryogenesis; however, no clearly defined function is ascribed to C5aR1 in development. Here we
demonstrate polarized expression of C5aR1 on the apical surface of mouse embryonic neural progenitor cells in vivo and on human
embryonic stem cell-derived neural progenitors. We also show that signaling of endogenous C5a during mouse embryogenesis drives
proliferation of neural progenitor cells within the ventricular zone and is required for normal brain histogenesis. C5aR1 signaling in
neural progenitors was dependent on atypical protein kinase C , a mediator of stem cell polarity, with C5aR1 inhibition reducing
proliferation and symmetric division of apical neural progenitors in human andmousemodels. C5aR1 signaling was shown to promote
themaintenance of cell polarity, with exogenous C5a increasing the retention of polarized rosette architecture in human neural progen-
itors after physical or chemical disruption. Transient inhibition of C5aR1 during neurogenesis in developing mice led to behavioral
abnormalities in both sexes and MRI-detected brain microstructural alterations, in studied males, demonstrating a requirement of
C5aR1 signaling for appropriate brain development. This study thus identifies a functional role for C5a–C5aR1 signaling inmammalian
neurogenesis and provides mechanistic insight into recently identified complement gene mutations and brain disorders.
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Introduction
The key complement activation fragment, anaphylatoxin C5a
and its primary receptor C5aR1, plays a pivotal role in inflamma-
tion and immune defense. However, it is increasingly recognized
that this evolutionarily ancient system also possesses unexpected
roles in development, such as in morphogenesis, neurogenesis,
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Significance Statement
The complement system, traditionally known as a controller of innate immunity, now stands as amultifaceted signaling family with a
broadrangeofphysiologicalactions.These includeroles inthebrain,wherecomplementactivationisassociatedwithdiseases, including
epilepsy and schizophrenia. This study has explored complement regulation of neurogenesis, identifying a novel relationship between
the complement activation peptide C5a and the neural progenitor proliferation underpinning formation of themammalian brain. C5a
was identified as a regulator of cell polarity, with inhibition of C5a receptors during embryogenesis leading to abnormal brain develop-
ment andbehavioral deficits. Thisworkdemonstratesmechanisms throughwhichdysregulationof complement causes developmental
disease and highlights the potential risk of complement inhibition for therapeutic purposes in pregnancy.
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migration, and neuronal synapse pruning (Hawksworth et al.,
2017; Gorelik et al., 2017). Defects in complement signaling have
been associated with neurodevelopmental abnormalities such as
autism, schizophrenia, and 3MC syndrome (Corbett et al., 2007;
Rooryck et al., 2011; Sekar et al., 2016).
Despite these emerging developmental roles of complement,
the functional role of C5aR1 in embryonic development remains
poorly defined. During organogenesis of Xenopus embryos, C5 is
expressed in the neural plate of the developing nervous system
(McLin et al., 2008), and in mice and humans, C5 and C5aR1 are
expressed in the developing neural tube (Denny et al., 2013).
Postnatally, C5a–C5aR1 expression continues in neural stem cells
in vitro, is expressed inmigrating neuroblasts in response to isch-
emia (Rahpeymai et al., 2006), and promotes the proliferation of
progenitor cells within the external granular layer of the postnatal
rat cerebellum (Be´nard et al., 2008). We also previously demon-
strated that C5 and C5aR1 are expressed in human embryonic
stem cells and can regulate pluripotency (Hawksworth et al.,
2014). This early embryonic expression pattern of C5aR1 in the
absence of other factors of the canonical pathogen-initiated com-
plement cascade (Jeanes et al., 2015) suggests that C5aR1 signal-
ing has adopted additional roles in mammalian development
beyond innate immunity. However, despite this clear expres-
sion of C5a receptors during brain development, a neurodevel-
opmental role for C5a remains poorly defined.
To investigate the role of C5aR1 in neural progenitor cell
(NPC) physiology, we used both mouse models and human em-
bryonic stem (hES) cells differentiated to a stage resembling the
ventricular zone of the developing brain. In these hES-derived
cultures, neural rosettes are formed that display apical polariza-
tion and interkinetic nuclear migration of periluminal cells, sim-
ilar to that seen during neurulation and in the cortical ventricular
zone (Shi et al., 2012; Ziv et al., 2015). The signaling mechanisms
in the control of rosette polarity are highly conserved, and the
localization of the Par3/Par6/protein kinase C  (PKC) complex
to the apical membrane is essential for self-renewal of neural
progenitors through the orchestration of the balance between
symmetric and asymmetric division (Fietz and Huttner, 2011).
Here we show that C5aR1 is a regulator of the apicobasal polarity
of neural stem cells and that the acute pharmacological blockade
of C5aR1 signaling during neurogenesis results in reduced ven-
tricular zone proliferation and cerebral disorganization, leading
ultimately to behavioral alterations. Collectively, our data reveal
that C5aR1 functions as a regulator of mammalian brain devel-
opment under normal physiological conditions in bothmice and
humans. This work complements recent studies documenting
mutations in complement activation pathways that contribute to
an increased risk of neurodevelopmental disorders.
Materials andMethods
Reagents. Mouse recombinant C5a (mC5a) was obtained from Sigma-
Aldrich and reconstituted in 0.25% BSA in PBS. Human isolated C5a
(hC5a) was obtained from CompTech. PMX53 was synthesized as de-
scribed previously (Pavlovski et al., 2012), stored lyophilized, and recon-
stituted in purified water before use.
Tissue collection and processing. All animal experiments in this study
were performedwith prior approval from the animal ethics committee of
TheUniversity of Queensland. Animal housing and time-mating ofmice
was provided by University of Queensland Biological Resources. Tissues
were collected after the mice were killed by cervical dislocation. Tissues
preserved for RNA/protein analysis were snap frozen in liquid nitrogen
and stored at80°C until extraction. Protein was extracted using mod-
ified RIPAbuffer prepared in house. Tissues used for histological analysis
were incubated at 4°C overnight in freshly prepared 4% paraformalde-
hyde (PFA). Tissues were prepared for cryosection by sequential passag-
ing through serial sucrose solutions (10, 20, and 30%), removed into
OCT for freezing, and sectioned at 12 m, unless otherwise stated.
Embryonic CSF was obtained from embryonic day 13.5 (E13.5) em-
bryos using a pulled glass pipette attached to a vacuum. Pooled CSF from
three litters was used in analysis of mC5a concentration through ELISA.
CSF was treated with EDTA (5 mM final concentration) to prevent coag-
ulation and extrinsic complement activation and stored at 80°C until
analysis.
RT-PCR and qPCR. RNA was extracted using RNeasy plus spin col-
umns (QIAGEN) and treated for genomic DNA contamination using
Turbo DNase (Invitrogen). All RNA was additionally checked for gDNA
contamination by PCR analysis. Primer sequences and PCR conditions
can be found in Table 1. qPCR was performed using SYBR green PCR
mastermix (Ambion) and machine settings according to the manufac-
turer’s instructions. The Ct method to assess fold change of gene
expressionwas used, and all data points within an individual samplewere
referenced back to r18s expression levels.
Western blot. Protein samples (20 g) were subjected to electrophore-
sis at 100 V on a 10% polyacrylamide gel until good separation was
achieved. Primary antibodies directed against C5aR1 (1:500, Hycult Bio-
tech, clone 10/92, RRID:AB_10130226), phospho-Erk (1:1000, CST, cat-
alog #9106, RRID:AB_331768), total-Erk (1:1000, Cell Signaling
Technology, catalog #9102, RRID:AB_330744), and -tubulin (1:
2000, Sigma Aldrich, clone TUB2.1, AB_10679259) were diluted in 0.5
odyssey blocking buffer (LiCor) and incubatedwith themembrane rock-
ing overnight at 4°C. Incubation with specific LiCor odyssey secondary
antibodies was performed according to the manufacturer’s instructions.
Blots were imaged using the LiCor odyssey system and software. Optical
densitometry values were derived from analysis of the image in ImageJ
(NIH, RRID:SCR_003070).
Immunofluorescence. Tissues or cells were blocked using 0.1% Triton
X-100/4% goat serum in PBS for 1 h. In the case of live staining for
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Table 1. PCR primer sequences and conditions
Name Species Use Forward (5–3) Reverse (5–3) Annealing temperature (°C) Product size (bp)
mC5aR1 Mouse RT-PCR ATGCTGATGCTGATGCTGATCG ATGCTGATGGCTGATCGTCGGATGCTGAT 60 562
mActB Mouse RT-PCR GTGGGCCGCCCTAGGCACCAG CTCTTTGATGTCACGCACGATTTC 60 103
mC5aR1 Mouse qPCR GGGATGTTGCAGCCCTTATCA CGCCAGATTCAGAAACCAGATG 60 131
mSox2 Mouse qPCR TAGAGCTAGACTCCGGGCGATGA TTTCGTGGTCTTGTTTAAGGCAA 60 296
m18s Mouse qPCR GATCCATTGGAGGGCAAGTCT CCAAGATCCAACTACGAGCTT 60 103
hC5AR Human qPCR TCCTTCAATTATACCACCCCTGA GGAAGACGACTGCAAAGATGA 60 139
hC5 Human qPCR ACTGAATTTGGTTGCTACTCCTC GTATTACTGGGACTCCTCCTACC 60 110
hACTB Human qPCR GCGGGAAATCGTGCGTGACATT GATGGAGTTGAAGGTAGTTTGGTG 60 232
hCDH2 Human qPCR ATCAACCCCATACACCAGCC GTCGATTGGTTTGACCACGG 60 128
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NE-4C cultures, a primary antibody was added to unfixed cells on ice for
30 min before fixation. Primary antibodies raised against mC5aR1
(HBT, clone 10/92, 1:200, RRID:AB_10130226), Pax6 (R&D Systems,
MAB1260, 1:500, RRID:AB_2159696), phosphohistone H3 (CST, cata-
log #9706, 1:1000, RRID:AB_331749), doublecortin (DCX; CST, catalog
#4604, 1:500, RRID:AB_561007), Sox2 (CST, catalog #3728, 1:500,
RRID:AB_2194037), acetylated -tubulin (Sigma Aldrich, catalog #T7451,
1:500, RRID:AB_609894), Zo-1 (Invitrogen, catalog #402300, 1:500,
RRID:AB_2533457), hC5aR1 (BD Biosciences, catalog #550733, 3 g/ml,
RRID:AB_393854), C5 (HBT, clone bb5.1, 1:250, RRID:AB_10992443),
Tubb3 (Millipore, MAB1637, 1:1000, RRID:AB_2210524), NCAD (Sigma Al-
drich,C3865,1:2000,RRID:AB_262097),Arl13b (NeuroMab, 73-287, 1:200,
RRID:AB_11000053), PKC (Abcam, ab59412, 1:250, RRID:AB_946308),
or isotype control antibodies were incubated overnight at 4°C. Ap-
propriate Alexa Fluor secondary antibodies (Invitrogen, 1:1000) were
incubated with the samples for 2 h at room temperature before counter-
staining (1g/ml DAPI, 5min) andmounting. For C5aR/PKC costain-
ing, the issue of using two rabbit antibodies was circumvented with the
use of conjugated Fab fragments and intermediate blocking with an un-
conjugated Fab fragment (Jackson ImmunoResearch Laboratories). All
immunofluorescence images were acquired via confocal microscopy
(DMi8, Leica Microsystems) and processed with ImageJ software. Fur-
ther image analysis was performed with either ImageJ or CellProfiler
software (Broad Institute, RRID:SCR_007358), as stated in relevant
sections.
mC5a ELISA. Maternal and embryonic brain sample concentrations
were determined by BCA assay (Thermo Fisher Scientific). Aliquots of
each sample were measured in technical triplicate for mC5a concen-
tration by ELISA (R&D Systems, RRID:AB_2067297) according to the
manufacturer’s instructions. mC5a concentrations were normalized to
protein concentration (nanograms per milligram, brain samples) or vol-
ume (nanograms per milliliter, CSF).
Neurosphere culture. Telencephalon from litters of E14.5 C57BL6/J
mice (RRID:IMSR_JAX:000664) were isolated and mechanically disso-
ciated. Cells were maintained in DMEM/F-12 medium supplemented
with 1 B27 supplement, L-glutamine, 10 ng/ml bFGF, 10 ng/ml EGF,
and penicillin/streptomycin. Isolated human rosettes weremaintained in
N2B27 throughout the neurosphere assay. To assess the effect of C5aR1
modulation on neurosphere growth, 103 cells at passage 3 were seeded
into eachwell of a 96-well plate in the presence or absence of 10 nMmC5a.
Wells were imaged after 1 week in culture, and the number and diameter
of neurospheres were assessed. Medium was replaced every 48 h. Before
treatmentwith 10 nMmC5a, cells were deprived of growth factors (bFGF/
EGF) for 6 h.
NE-4C culture. NE-4C cells were acquired from the American Type
Culture Collection (catalog #CRL-2925, RRID:CVCL_B063) and ex-
panded inMEM (Sigma-Aldrich) supplemented with 10% FCS (Lonza),
L-glutamine, and nonessential amino acids (Invitrogen). For transwell
culture, NE-4C cells were plated on poly-L-lysine-coated 0.2 m trans-
well membranes in a 24-well plate. Cells were maintained in medium as
described above, and treatment (mC5a or vehicle) was added to the
upper compartment 12 h before fixation for immunofluorescence.
Human embryonic stem cell culture and neuronal differentiation. H9
hES cells (RRID:CVCL_9773) were maintained on Matrigel (BD
Biosciences)-coated dishes in mouse embryonic fibroblast-conditioned
KSR medium [DMEM/F-12 supplemented with 20% KnockOut Serum
Replacement (Invitrogen) and 0.1 mM nonessential amino acids, 1 mM
L-glutamine, 0.1 mM -mercaptoethanol, and 10 ng/ml human basic
fibroblast growth factor (FGF2), all from Thermo Fisher Scientific] as
described previously (Briggs et al., 2013). Neuronal induction was per-
formed using an adaptedmethod of dual SMAD inhibition (Chambers et
al., 2009). Briefly, high-densityH9 cells were incubated for 10 d inN2B27
medium (1:1 mixture of DMEM/F-12 supplemented with N2 and Neu-
robasal medium supplemented with B27, 0.1 mM nonessential amino
acids, 1mM L-glutamine, 0.1mM-mercaptoethanol, 50 U/ml penicillin,
and 50 mg/ml streptomycin) supplemented with 1 M Dorsomorphin
and 10 M SB431542. At day 10, cultures were bulk passaged using 1
mg/ml dispase solution and seeded on Matrigel-coated plates in N2B27
medium without Dorsomorphin and SB431542. The cultures passaged
again using a similar technique at day 15, maintaining bulk and high-
density culture. Cells were supplementedwith 2 ng/ml FGF2 fromday 16
to day 22 to promote emergence and proliferation of rosettes. Using this
method, rosettes began to emerge around days 16–18, reachingmaturity
7–10 d later. To ensure purity of neuronal cultures, rosettes were manu-
ally harvested around day 24.
Human neural rosette experiments. Rosette cultures were single cell
dissociatedwith Accutase (Thermo Fisher Scientific) and seeded at either
high density (3.2 105 cells/cm2) or low density (1.2 105 cells/cm2)
for subsequent experiments. At high density, 100% of cells re-formed
rosettes, allowing for experimentation on a pure culture of uniformly
sized rosettes. At low density, the ability of rosette re-formation was
limited (see Results), allowing for interrogation of the ability of C5aR1
signaling to promote reestablishment of rosettes over differentiation.
Low-density single cells were grown for 7 d in the presence of 10 nM
hC5a, 1 M PMX53 plus hC5a, or vehicle control, after which cells were
fixed in 4% paraformaldehyde and stained for NCAD using the above
immunocytochemistry methods protocol. Acquired images were ana-
lyzed using CellProfiler (RRID:SCR_007358) to quantify rosette number
through the measurement and quantification of NCAD-positive rosette
lumens (Kamentsky et al., 2011).
High-density single cells were cultured for 5 d to allow reestablishment
of rosettes, after which cells were tested inDAPT treatment and cell-cycle
progression experiments. For DAPT treatment, cells were pretreated
with 10 nM hC5a or vehicle control for 1 h, after which 1 M DAPT was
added. Cells were incubated overnight, after which they were fixed,
stained for NCAD, imaged, and analyzed with CellProfiler to quantify
rosette number or RNA collected for qRT-PCR. For cell-cycle testing,
cells were serum starved overnight in DMEM/F-12 plus 0.25%BSA, after
which 10 nMhC5a or vehicle control was added to the cells. The cells were
then incubated overnight, after which they were fixed and stained with
anti-phosphorylated histone H3 (pHH3) antibody and DAPI using the
above immunocytochemistry methods protocol. The ratio of pHH3-
positive nuclei was calculated using analysis with CellProfiler.
In utero injections. Time-mated dams at E13.5 were anesthetized un-
der 1% isofluorane for surgery. One microliter of 100 nM mC5a, 10 M
PMX53, or respective vehicle control was injected into the ventricular
system of the embryos. Abdominal incisions were closed with sutures,
and dams were administered 0.1 mg/kg buprenorphine for analgesia
after surgery. Dams were killed and tissues were collected at 24 h after
surgery for tissue analysis.
For analysis of proliferation, the embryonic telencephalon was sec-
tioned coronally, and sections at the level of the preoptic area were used
for histological analysis. M-phase cells, as determined by phosphohis-
tone H3 staining, were counted using ImageJ at the apical surface of the
telencephalic ventricular zone. Phosphohistone H3-positive cells per 100
mwere calculated for each individual embryo, and differences between
treatment groups were analyzed by Students t test.
Treatment of animals for behavioral experiments and magnetic reso-
nance imaging. Time-mated dams were acquired from UQBR and
housed under standard conditions under the care of animal house staff.
Mice were administered 1 mg/kg PMX53 or sterile water vehicle control
(n 6 per group) in a 100 l volume via intraperitoneal injection over
3 d (E12.5–E14.5). Dams were allowed to litter down in individual cages.
Gestational age at birth was defined as the number of days after discovery
of the vaginal plug (E0.5). Litter number, weight, crown-rump length,
and snout-occiput length were taken at birth. In addition, pup weight
was tracked over the first 5 weeks of life to determine whether any differ-
ences existed in growth parameters.
At 8weeks of age,male and femalemice from the litters were randomly
selected for participation in behavioral experiments (n  8 per group).
After behavioral experiments, mice were anesthetized with a zylazine/
xoletil mixture and perfused with PBS, followed by 4% PFA via an
intracardiac cannula. Whole heads were incubated in 4% PFA for an
additional 3 d before washes with PBS and careful removal of the brain.
Brains were stored in fresh PBS until magnetic resonance imaging (MRI)
analysis.
Grip strength. Mice were assessed for motor weakness using the grip
strength test. Briefly, mice gripped a bar attached to a force transducer.
Coulthard, Hawksworth et al. • C5aR1 Drives Neural Progenitor Proliferation J. Neurosci., May 31, 2017 • 37(22):5395–5407 • 5397
The experimenter gently pulled backward on the base of the tail until the
mouse dislodged from the bar. The maximum force recorded over three
trials was designated as the grip strength. Both forelimb and hindlimb
grip strength was assessed.
Balance beam.Micewere assessed for highermotor coordination using
the balance beam test. The apparatus consisted of a 70 cm (length) 3
mm (width) beam suspended 1m above a surface. The beamwas held in
a room with bright overhead lights kept at a constant output of 150
lumens, and a covered platformwas set at the end of the beam.Mice were
trained, through four training attempts, to move toward the covered
platform through the use of a training beam of 80 mm width. After
training,mice were exposed to the test apparatus. Time taken to cross the
beam and footfall errors were recorded. A footfall error was deemed to
have occurred if the paw of the animal moved from a position on the
beam and crossed a threshold 10 mm beneath the beam.
Open-field test. The open-field test used 50  50 cm infrared photo-
beam tracking arenas (MED Associates) to measure activity in a novel
environment.Mice were placed in the center of the arena, and after a 30 s
initiation period, movement in the x, y, and z planes was tracked for the
following 30 min. Arenas were cleaned with 70% ethanol and allowed to
dry between experiments. Thigmotaxis over the initial 5 min was used as
a measure of anxiety in the new environment and was assessed as beam
breaks within the center (25 25 cm) square of the arena.
Y-maze. The Y-maze consisted of a Y-shaped maze of opaque white
plastic with three identical arms set at 120° angles. The arms consisted of
a home arm of plain design and two exploratory arms where the walls
were decorated with different repetitive geometric patterns. For the ex-
ploratory task, one exploratory armwas blocked from themaze by use of
a plastic divider. A subject was placed in the home arm and allowed to
explore the home arm and remaining exploratory arm for 5 min. The
subject was then reintroduced to the maze after a 30 min period with the
arm divider removed, allowing for entry into the second novel, explor-
atory arm. The movement of the mouse around the maze was tracked
with EthoVision video tracking software (Noldus). Frequency of entry
into the novel arm was used as a measure of short-term memory.
MRI analysis of brain regions. Brains stored for MRI analysis were
washed extensively in PBS, followed by a 48 h incubation in gadolinium
contrast agent [0.2% Magnevist (Bayer Healthcare Pharmaceuticals) in
PBS]. Brains were imaged on 16.4T small-animal vertical wide bore
NMR spectrometer (Bruker BioSpin) at the Centre for Advanced Imag-
ing, The University of Queensland. Brains were immersed in fomblin oil
(Solvay Solexis) inside a glass test tube of 10 mm diameter and fitted
inside a quadrature birdcage coil (M2M Imaging). T1-weighted images
and multishell diffusion-weighted images (DWIs) were obtained within
a total scan time of 18 h as described previously (Sepehrband et al., 2015).
Briefly, DWI datasets were composed of three B0 images and 60 diffusion-
weighted images for each shell. Optimally ordered gradient directions
with electrostatic energy minimization were obtained using the Camino
software package (Jones et al., 1999; Cook et al., 2007).
Volumetric analysis of the obtained T1 images was achieved using
Advanced Normalization Tools software. Briefly, all T1 images were
warped to produce a common template image. Warp fields containing
Jacobian values for the individual images were subjected to a modified t
test using the randomize function of FSL (Oxford Center for Functional
MRI of the Brain Software Library) to determine significantly different
Jacobian value voxels between the vehicle- and PMX53-treated groups.
Inverse warp fields were applied to anatomical areamapping of the com-
mon template to generate volumetric values for regions of sample brains.
T1 images and generated anatomical masks were visualized and refined
in ITKsnap software (University of Pennsylvania). Differences in brain
region volume were tested using Student’s t test.
Images were registered using the FSL linear registration tool to com-
pare anatomically similar voxels between samples. Comparison of each
of the diffusion parameters was achieved using the randomize function of
FSL to generate a probability map of differences between vehicle- and
PMX53-treated samples. Probability maps were thresholded to signifi-
cance (p 0.05) and displayed on a generated template image.
Statistical analyses. Graphing and statistics were performed using
GraphPad Prism software (version 6.0c, GraphPad Software) using Stu-
dent’s t test and one-way ANOVA with Dunnett’s post-test for the rele-
vant statistical analysis.
Results
C5aR1 is expressed in murine neural progenitor cells and is
localized to the apical ventricular zone
We have previously reported the neuroepithelial expression of
C5aR1 during mouse neurulation (E7.5–10.5; Denny et al.,
2013), but it is unknown whether C5aR1 expression continues
during the period of neurogenesis. We therefore examined the
temporal expression of C5aR1 in embryos 12.5–18.5 dpc. RT-
PCR analysis of whole-brain RNA extracts revealed C5ar1 ex-
pression during this key period of brain formation (Fig. 1A).
Immunohistochemistry analysis indicated that C5aR1 protein
was distinctly localized to the apical surface of the ventricular
zone (Fig. 1A). The ligand of C5aR1, mC5a, was detected at very
low levels in embryonic and adult brain tissue; however, it was
found at much higher levels in CSF sampled from E14.5 embry-
onic ventricles, but not adult mouse CSF (Fig. 1D). Human con-
cordance with these results has recently been reported, with hC5a
detected in the CSF of newborn infants (Pataky et al., 2016).
Importantly, these embryonicmC5aCSF concentrations equated
to 1.4 nM, a functionally active concentration for this potent
signaling peptide (Hawksworth et al., 2014).
We next demonstrated that C5aR1 expression is maintained
ex vivo in neurospheres derived from the telencephalon of E14.5
mice, and the immortalized neural progenitor cell line NE-4C, as
determined by RT-PCR analysis (Fig. 1A) and immunocyto-
chemistry (Fig. 1B,C). Interestingly, differentiation of theNE-4C
line with retinoic acid, confirmed by downregulation of Sox2,
caused a statistically significant reduction in C5aR1 mRNA be-
tween stages II and IV (Fig. 1F), a period that corresponds to the
beginning of neurogenesis and migration in the cultures (Schlett
and Madara´sz, 1997). No reduction of C5aR1 protein was de-
tected until stage VI, a period that marks the onset of gliogenesis
(Fig. 1E). The discordance in timing betweenmRNA and protein
signal loss reflects previous measurements of protein half-life in
culture (Schwanha¨usser et al., 2011). Overall, this indicates that
C5aR1 retains a polarized localization in neural progenitor
cells ex vivo and that expression of the receptor reduces as cells
differentiate.
C5aR1 is apically localized in human embryonic stem
cell-derived neural progenitors
To explore the role of C5aR1 in a human setting, we first assessed
whether the mouse apical neural localization of C5aR1 was con-
served in human tissue. We have previously reported C5aR1 ex-
pression in a similar localization to mouse, with staining for
C5aR1 restricted to the cortical ventricular zone of Carnegie stage
13 human neural tissue (Denny et al., 2013). To further assess
C5aR1 localization and function in humandevelopment, we used
hES-derived neuronal progenitors as an in vitromodel system. To
this end, hES cells were differentiated into cortical neural rosettes,
a stage with characteristics analogous to the cortical ventricular
zone (Shi et al., 2012; Ziv et al., 2015). The cells in these human
neural rosettes expressed the neural markers TUBB3 and NCAD,
with strong expression of the tight junction marker ZO-1 on the
apical luminal surface of each rosette, indicative of the distinct
apicobasal polarity that defines the rosette architecture (Fig. 2A).
C5aR1 expression was robustly detected at the apical surface of
rosettes, where it colocalized strongly with the apical membrane
marker atypical PKC but not withmarkers of cell–cell junctions
(NCAD) or cilia (Arl13b), suggesting that the protein is confined
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to the apical plasma membrane (Fig. 2A). In neural progenitor
cells, the apical membrane attachment acts as an anchor for de-
terminants of polarity such as the Par3/Par6/PKC complex,
which together with apical NCAD-based adherens junctions
maintains tissue architecture and apicobasal polarity (Go¨tz and
Huttner, 2005). Interestingly, we observed a close correlation
between NCAD and C5aR1 expression levels during the neural
differentiation of hES cells. Upregulation of NCAD after neural
induction peaked at the rosette stage and decreased after further
maturation of the cultures. Both C5aR1 and C5 closely followed
this pattern of expression (Fig. 2B). C5 protein expression ap-
peared diffuse and punctate throughout the rosettes (Fig. 2A),
and the processed form of C5, hC5a, was detectable in the lysate
of rosette cells at a similar time point (Fig. 2C). High lysate levels
of C5a may reflect intracellular stores of C5a, as has been ob-
served and discussed previously for the complement anaphyla-
toxins (Pavlovski et al., 2012; Hawksworth et al., 2014; Elvington
et al., 2017). These results indicate that human subcellular and
temporal C5aR1 expression during development closely mirrors
that observed in developing mouse brain.
C5aR1 signals via PKC and Erk in mouse and human neural
progenitors to promote polarization and proliferation
Intrigued by the unique apical localization of C5aR1 in vivo and
in vitro, and the well described importance of the apical mem-
brane and PKC in controlling progenitor pool proliferation, we
next assessed the functional role of C5aR1 in these processes. In
mouse neurosphere cultures, mC5a addition caused an increase
in p42/44 (ERK) phosphorylation (Fig. 3A), which could be ef-
fectively inhibited through pretreatment with a specific PKC
pseudosubstrate inhibitor (Fig. 3B). Similarly, in human rosette
cultures, treatment with humanC5a caused an increase in p42/44
phosphorylation that was attenuated through pretreatment with
either a selective C5aR1 antagonist (C5aR1-A, PMX53) or with
PKC inhibition (Fig. 3C), indicating that C5aR1 signaling is
conserved between human andmouse. Given the association be-
Figure 1. Localization of C5aR1 and ligands. A, C5aR1 (red) is expressed in the developing neocortex at the apical surface of the ventricular zone at E14.5 (top row). Shown is
counterstain with Pax6 (green) and DAPI (blue). Scale bar, 50m. Merged images of the ventricular zone at E12.5, E16.5, and E18.5 are shown in the second row. RT-PCR demonstrates
C5aR1 expression in embryonic brain tissue, neurosphere, and NE-4C culture. B, C5aR1 expression (red) within sectioned neurosphere. Neg, Secondary-only negative control. Scale bar,
50m. C, C5aR1 expression (red) on NE-4C cells grown in monolayer. Neg, Secondary-only negative control. Scale bar, 20m. D, Embryonic CSF contains mC5a at significantly greater
concentrations than brain tissue or maternal CSF. E, C5aR1 is detected within NE-4C cultures by Western blot at the predicted molecular weight (50 kDa) and decreases at stage VI of
differentiation. Stages indicate morphologically distinct progression of NE-4C differentiation (see Materials and Methods). F, Expression of C5aR1 mRNA decreases with differentiation
of NE-4C cells. Progenitor marker Sox2 is assayed as a comparison. *p 0.05, **p 0.01, ***p 0.001.
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Figure 2. Expression of C5aR1 in human embryonic stem cell-derived rosettes. A, Immunocytochemistry of human neural rosettes showing staining for neural marker TUBB3, tight junction
marker ZO-1, and C5. C5aR1 localizes to the apical membrane, colocalizingwith PKC, but notmarkers of cilia (Arl13b) or tight junctions (NCAD). Negative controls are shown at top right. Scale bar,
20m. B, Transcript expression as hES cells (day 0) are differentiated through the cortical rosette stage (day 28) to a mature neuronal lineage. C5AR1 expression is highest at the rosette stage of
neuronal differentiation. C, hC5a is detected through ELISA within the lysate of rosette cultures and is not derived from the exogenous extracellular matrix (Matrigel). *p 0.05, **p 0.01.
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tween ERK signaling and mitogenic activity, we investigated the
ability of C5aR1 signaling to modulate neural progenitor prolif-
eration. Daily addition of species-specific C5a to neurosphere
cultures resulted in an increase in both number and diameter of
mouse and human neurospheres over a 7 d period (Fig. 3D–G).
Additionally, in human neural rosette cultures, the addition of
C5a led to a 59% increase in pHH3-positive nuclei, indicative of
increased mitotic activity within rosettes (Fig. 3H).
The observation that C5aR1 signaling is mediated by PKC, a
component of the Par3/Par6/PKC cell polarity complex, com-
bined with its localization at the apical membrane of neural ro-
settes strongly supports a role for C5aR1 in controlling NPC
polarity. We therefore examined the role of C5aR1 in NPC po-
larity signaling pathways. Previous studies have shown that a loss
of paracrine Notch signaling results in downregulation of NCAD
and the loss of apicobasal polarity (Main et al., 2013). Treatment
of human neural rosettes with the Notch signaling inhibitor
DAPT significantly decreased the expression ofNCAD, leading to
a disruption of cell–cell contacts and inducing a loss of rosette
architecture (Fig. 3I). Interestingly, both C5aR1 and C5 expres-
sion also decreased with DAPT treatment, which may indicate
polarity-dependent expression of these complement factors (Fig.
3I). Single-cell dissociation of rosettes also interferes with para-
crine signaling and cell–cell contact, resulting in loss of cell po-
larity and impaired rosette formation. Exogenous addition of
hC5a maintained rosette architecture in the presence of DAPT
(Fig. 3J) and promoted reestablishment of rosette architecture
after dissociation, an effect that was blocked after C5aR1 antago-
nism (Fig. 3K). We conclude that C5aR1 is not only dependent
on but also actively promotes cell polarity.
This promotion of polarity was also observed in mouse-
derived NE-4C cells cultured on transwell plates. The addition of
exogenous mC5a led to restriction of the apical surface area by
50%, as measured by ZO-1 staining, and microtubule-organizing
center localization in these cells was significantly closer to the
apical center, indicative of the induction of cell polarization
(Fig. 3L,M). Collectively, these data confirmed the polarity-
dependent expression of C5aR1, an involvement of C5aR1 sig-
naling in the maintenance of neural progenitor polarity and,
subsequently, proliferation.
C5aR1 signaling increases the proliferation of neural
progenitor cells of the embryonic ventricular zone in vivo
Having defined a role for C5aR1 in NPC proliferation and estab-
lishment of cell polarity in vitro, we next wished to assess its role
in mouse brain development by in utero delivery of mC5a or
C5aR1-A (PMX53) into the embryonic ventricle of E13.5 mouse
embryos (Fig. 4A). We observed that 24 h after a single injection
Figure 3. C5aR1 signals through PKC to maintain cell polarity in vitro. A, Mouse neurosphere cultures demonstrate C5a concentration-dependent p42/44 phosphorylation. B, The response to
100 nM C5a is prevented by PKC inhibition. C, Human rosette cultures demonstrate time-dependent p42/44 phosphorylation to 10 nM hC5a. The response is prevented through pretreatment with
C5aR1-A or PKC inhibition.D–G, Mouse and humanneurosphere cultures dissociated and grownover a 7 d period demonstrate an increase in number (D, F ) and diameter (E,G) in response to C5a.
H–K, Treatment of human rosettes with 10 nM C5a.H, C5a increases M-phase-positive cells in neural rosettes as determined by pHH3 immunocytochemical analysis. I, DAPT (gray bars) treatment
induced loss of rosettes and a decrease inmRNA of NCAD, C5AR1, and C5 compared with vehicle (black bars) treatment. J, K, Maintenance of rosette architecture after single-cell dissociation (K ) or
DAPT treatment (J ) was promoted by exogenous C5a addition. Adjacent images are representative of DAPT-treated rosettes in the presence or absence of C5a. NCAD (white) and computational
outlines (green) of rosette apical lumens are shown. L, M, NE-4C cells grown on transwell membranes demonstrate reorganization of the mitotic spindle (L), as determined by acetylated tubulin
staining (green), and reduction in apical surface area (M ), outlined by ZO-1 (red) in response to C5a.White arrows are representative distances frommitotic spindle to calculated cell center as shown
in L. Scale bar, 20m. Veh., Vehicle. *p 0.05, **p 0.01, ***p 0.001.
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of mC5a, there was a twofold increase in
the number of apical progenitors in theM
phase of the cell cycle, as indicated by
pHH3 staining (Fig. 4B). In contrast,
blockade of C5aR1 signaling resulted in a
decrease in the number of M-phase apical
progenitors after 24 h (Fig. 4B). Analysis
of the cleavage plane of actively dividing
cells in these samples demonstrateda signif-
icant shift from symmetric to asymmetric
division after C5aR1-A injection (Fig. 4C).
We conclude that C5aR1 signaling pro-
motes NPC proliferation in vivo and affects
the balance between symmetric and asym-
metricdivision, in concordancewith in vitro
observations.Combinedwith the robust ex-
pression of mC5a in embryonic CSF (Fig.
1D), this supports an endogenous physio-
logical role formC5a–C5aR1 signaling dur-
ing embryonic neurogenesis.
Blockade of C5aR1 from E12.5 to E14.5
results in behavioral abnormalities in
the adult mouse
Given that acute disruption of C5a–C5aR1
signaling affects proliferation of apical
progenitors and the balance between sym-
metric and asymmetric cell division, we
next determined whether acute phar-
macological blockade of C5aR1 during
neurogenesis translates into behavioral
abnormalities later in life. Time-mated
dams were intraperitoneally injected daily
with 1 mg/kg C5aR1-A during the critical
neurodevelopmental window (E12.5–E14.5),
and resultant litters were subjected to be-
havioral testing between 6 and 8 weeks of
age (Fig. 5A). We first confirmed that in-
traperitoneal delivery of C5aR1-A over
the 3 d embryonic window resulted in im-
paired neurogenesis. Compared with ve-
hicle controls, C5aR1-A-treated embryos
displayed a reduction in the size of the
ventricular zone, as measured by Sox2
staining, and an increase in the thickness
of the maturing cortex, as demonstrated
by the postmitotic maturing neuron
marker DCX at E16.5. This collectively re-
sulted in a significant decrease of the Sox2/
DCX ratio (Fig. 5B). We next assessed
whetherC5aR1-A treatment resulted in any
gross developmental or pregnancy com-
plications. C5aR1-A-treated pups showed no change in postnatal
growth (Fig. 5C), litter size (Fig. 5D), and snout-occiput length
(Fig. 5F); however, a minor, but significant, reduction in crown-
rump length was observed (Fig. 5E).
Adultmicewere next subjected to a series of behavioral tests to
assess neuromotor and cognitive function. In utero C5aR1-A-
treated mice demonstrated significant behavioral abnormalities
in adulthood. In motor control tasks, there was no difference in
grip strength (Fig. 5G); however balance beam testing of centrally
controlled motor coordination tasks showed an increase in both
footfall errors and time taken to cross the beam for C5aR1-A-
treated mice (Fig. 5H, I). In an open-field test, C5aR1-A-treated
animals of both genders demonstrated a decrease in distance
traveled in the center areas of the cage (Fig. 5J), suggesting
heightened anxiety in a novel environment. The Y-mazewas used
to assess short-term memory, and frequency of entry into the
novel arm was reduced in C5aR1-A-treated animals (Fig. 5K).
Finally, the forced swim test was used to assess depressive-like
symptoms, where C5aR1-A-treated animals spent significantly
reduced time being immobile comparedwith nontreated animals
(Fig. 5L). These results clearly demonstrated that acute in utero
blockade of C5aR1 signaling over a relatively short time frame led
Figure 4. C5aR1 signaling alters neural progenitor division planes and proliferation in vivo. A, Schema of the in utero injection
process. Briefly, 1l of 100 nMmC5a, 1M PMX53, or vehicle was delivered to the embryonic ventricle in utero. After 24 h, brains
were processed for immunohistochemistry. M-phase cells, as determined by pHH3 staining, were counted along the ventricular
surface of the neocortex. B, In utero injection of mC5a to the embryonic ventricle increases, whereas blockade of C5aR1 signaling
using PMX53 decreases, the number of M-phase apical progenitor cells. C, Cleavage plan analysis demonstrates a shift from
symmetric division toward asymmetric division after treatment with C5aR1 antagonist. S, Symmetric division; A, asymmetric
division; O, oblique division; Veh., vehicle. **p 0.01, ***p 0.001.
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Figure 5. Blockade of C5aR1 signaling at E12.5–E14.5 causes behavioral changes in adult mice. A, Schema of the experimental process. Briefly, 1 mg  kg1  d1 of the C5aR1 antagonist
PMX53was delivered by intraperitoneal injection to pregnant dams at E12.5–E14.5. Resultant litters were taken through behavioral testing from 6 to 8weeks and killed, and brains were prepared
for ex vivoMRI. Data show results for vehicle (V, black bars)- andPMX53 (P, gray bars)-treatedmice.B, Sox2/DCX ratio of the ventricular zone of E16.5 embryos.C,D,F, No change in postnatal growth
(C), litter size (D), and snout-occiput length (F ) was seen. E, A significant reduction in crown-rump length was observed. G, No difference between treatment groups was found in grip strength for
both forelimb (F) and hindlimb (H).H, Time to cross balance beamwas increased inmale animals fromPMX53-treated litters. I, Footfall errors crossing balance beam. J–L, Distancemoved in center
of open-field arena (J ), frequencyof entry tonovel armY-maze (K ), and time spent immobile during the forced swimtest (L)were significantly different inPMX53-treated litters. Veh., Vehicle; Fem.,
female. *p 0.05, **p 0.01, ***p 0.001.
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to a range of behavioral discrepancies that involved several ana-
tomically distinct systems such as memory, coordination, and
anxiety.
In utero blockade of C5aR1 between E12.5 and E14.5 results
in microstructural differences onMRI analysis
Given the broad behavioral deficits induced by transient in utero
C5aR1 antagonismbetween E12.5 andE14.5 of gestation, we next
used ex vivo 16.4T MRI to identify structural alterations in the
brain that could underlie the observed phenotypes. Firstly, a Ja-
cobianmapwas used tomeasure the relative change of each brain
structure required to fit to a template image, therefore identifying
any volumetric change in distinct regions between sample groups
(Lepore´ et al., 2007). C5aR1-A-treated animals showed signifi-
cantly increased clusters of Jacobian values throughout the cortex
and striatum (Fig. 6), indicating that spatial expansion was re-
quired to fit individual images to the template in these areas
(Lepore et al., 2008). However, volumetric analysis of segmented
brain regions (Ma et al., 2005) failed to show significant differ-
ences between groups (Table 2). These areas of volume difference
correlated withmicrostructural difference as shown by fractional
anisotropy (FA). FA values were higher in the frontal cortex,
striatum, and hypothalamus of C5aR1-A-treated animals (Fig.
6), alluding to increased myelination, increased axonal den-
sity, or a reduction in fiber dispersion in these areas (Sepeh-
rband et al., 2015), which may account for the behavioral
differences seen between these two experimental groups
(Soares et al., 2013). Overall, these results demonstrate multi-
ple microstructural differences induced by C5aR1 inhibition
in embryos, which are concordant with the behavioral deficits
seen in these mice.
Discussion
Proteins of the complement system are present during embryo-
genesis, playing novel roles in development (McLin et al., 2008;
Denny et al., 2013; Jeanes et al., 2015). Our laboratory has previ-
ously demonstrated their presence and function on human em-
bryonic stem cells and mouse neuroepithelial cells (Denny et al.,
2013; Hawksworth et al., 2014). Additionally, we have previously
shownC5aR1 expression on the apical neuroepithelium at a sim-
ilar developmental stage to this study, in nonpathological human
embryos (Denny et al., 2013), raising the question of roles for
complement in normal embryonic development. Here we show
that in both human and mouse models, the key complement
effector system, C5a–C5aR1 signaling, functions to control pro-
Table 2. MRI volume comparison of brain regions for C5aR1-antagonist or vehicle-
treatedmice
Area
Vehicle treatment C5aR1-A treatment
p valueVolume (mm3) SE n Volume (mm3) SE n
Amygdala 10.24 0.1425 7 10.18 0.2929 9 0.8764
Caudate/putamen 23.25 0.4326 7 22.85 0.5933 9 0.6175
Corpus callosum and
external capsule
8.213 0.102 7 7.891 0.331 9 0.4203
Central gray matter 4.476 0.05 7 4.339 0.07 9 0.1762
Cerebellum 46.96 0.3563 7 42.83 1.764 9 0.0624
Fimbria 2.007 0.028 7 1.928 0.05576 9 0.2702
Globus pallidus 2.485 0.055 7 2.368 0.046 9 0.1209
Hippocampus 24.71 0.287 7 24.31 0.5846 9 0.5832
Hypothalamus 11.61 0.162 7 11.17 0.284 9 0.234
Neocortex 125.5 1.84 7 121.5 3.45 9 0.3668
Olfactory bulbs 17.88 0.2216 6 16.53 0.7673 9 0.1858
Thalamus 25.19 0.095 7 24.69 0.732 8 0.5444
Figure 6. Blockade of C5aR1 signaling at E12.5–E14.5 results in microstructural changes in adult brains. Top row, Significance map of Jacobian warping projected onto T1-weighted template
average.Middle row, Significancemapof FA values projected onto template average. For bothmaps: blue/purple, vehiclePMX53 (C5aR1-A) treatment; red/yellow, PMX53vehicle. Color-coded
p values are shown at the bottom. Bottom row, Anatomical areas are labeled. Mot., Motor cortex; Orb., orbital cortex; OB, olfactory bulb; SS, somatosensory cortex; Gust., gustatory cortex; Pir.,
piriformis; CP, caudate/putamen; NA, nucleus accumbens; P., pallidum; H., hypothalamus; Veh, vehicle.
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genitor cell polarity, proliferation, and the symmetry of the cell
division. Ultimately, this loss of C5aR1 signaling manifests as
altered cerebral organization and behavioral deficits.
In neural progenitor cells of the ventricular zone, the loss of
apical attachment where C5aR1 resides is associated with de-
creased expression of factors responsible for the maintenance of
stemness. Asymmetric inheritance of this attachment during mi-
tosis is a catalyst for differentiation toward a postmitotic state,
with loss of attachment initiating exit from the ventricular zone
pool, and subsequent maturation into neuronal subtypes (Go¨tz
and Huttner, 2005; Miyamoto et al., 2015). Conversely, symmet-
ric division of the apicalmembranemaintains both daughter cells
within the ventricular zone progenitor pool, secondary to con-
tinued signaling from the apical membrane. The apically local-
ized PKC is an essential second messenger in the promotion of
symmetric division and the maintenance of neuroepithelial ar-
chitecture (Ghosh et al., 2008). However, less is known about the
receptors that trigger PKC activation. Here we have identified
C5aR1 as a novel prime candidate, with polarized apical expres-
sion, for controlling endogenous PKC signaling during mam-
malian corticogenesis.
In addition, we have shown a plausible biological source for
C5aR1 stimulation within the CSF of the developing embryo,
which were at higher concentrations than both embryonic brain
tissue and adult CSF. This may suggest that C5a is actively se-
creted into the CSF to stimulate proliferation of progenitor cells,
given that concentrations are higher during development than in
adulthood. The source of this C5a will require further delinea-
tion; however, we demonstrated C5 expression within neural ro-
sette cultures (Fig. 2A). As the CSF was assayed before the advent
of ependymal cell differentiation, this strongly suggests an auto-
crine production of C5a by neural progenitor cells.
These findings are particularly of interest in light of previous
reports demonstrating that, in adult mice, C5aR1 does not con-
tribute to basal neurogenesis (Bogestål et al., 2007). This appears
to contrast with our study, which identifies a role for C5aR1 in
neurogenesis, albeit at an earlier stage of life than investigated by
Bogestål et al. (2007). However, the receptor has also been dem-
onstrated on migrating neuroblasts in models of cerebral isch-
emia (Rahpeymai et al., 2006), leading to somequestion of its role
on these cells, given an apparent noncontributory role to neuro-
genesis. Although not directly tested, it could be argued that
C5aR1 is responsive on neuroblasts to the higher C5a concentra-
tions in the ischemic brain but has a dormant role in the non-
pathological and, therefore, low-C5a setting.
The present discovery adds to previous studies that have
identified neurodevelopmental deficits associated with aber-
rant complement activity, including in disorders such as autism,
schizophrenia, and epilepsy (Hawksworth et al., 2017). For ex-
ample, the fetal neurocognitive injury associated with maternal
malaria infection has been shown to be mediated by C5aR1 (Mc-
Donald et al., 2015). Furthermore, allele variations leading to
increased complement factor 4A (C4A) expression have been
correlated to increased schizophrenia risk (Sekar et al., 2016). It is
interesting to speculate, given our findings, on whether the be-
havioral deficits demonstrated in both diseases are the result of a
direct effect of C5aR1 signaling on neural progenitors, altering
corticogenesis, rather than the alternate hypothesis of a general-
ized inflammation and altered synaptic pruning. Within this
hypothesis, classical complement cascade activation would ines-
capably lead to the formation of C5 convertases, and activation of
C5. Given our identification of a mechanistic role for C5aR1 in
ventricular zone progenitors and cerebral organization, it could
equally be hypothesized that the increased C4A and classical
complement cascade activation increases cerebral C5aR1 signal-
ing, with consequent alterations in progenitor migration driving
the complex cortical pathology associated with schizophrenia
risk. Additionally, it is interesting that the shortwindowofC5aR1
blockade used in our studieswas also not compensated for later in
development, as demonstrated by the behavioral and brain mi-
crostructural differences in adult mice. In contrast, there is a
demonstrated functional compensation of impaired synaptic
pruning resulting from other models of complement deficiency
(Perez-Alcazar et al., 2014). This theory is supported by the find-
ing of impaired short-term memory in C5aR1 knock-out animals
(Gong et al., 2013), indicating that disruption of the receptor signal-
ing, but not the cascade, is enough to alter neuronal circuitry.
Given the potential disparity between animal and human cog-
nitive development, one focus of this study was to validate obser-
vations made in the mouse model in a human environment. We
have previously shown expression of C5aR1 in human embryos,
at Carnegie stage 13, where it is also localized to the apical neu-
roepithelium (Denny et al., 2013). The combination of this in
vivo localization with the results presented in this study, demon-
strating human neural progenitors signaling through C5aR1 in a
similar manner to the mouse, strongly suggests conservation of
C5aR1 function between mouse and human. C5aR1 is already a
strong candidate target for direct therapeutics against inflamma-
tory diseases of pregnancy. Maternal complement dysregulation
is a factor in the pathogenesis of preeclampsia and infection-
related preterm birth (Lokki et al., 2014; Denny et al., 2015).
Interestingly, the humanized IgG2/4 monoclonal antibody di-
rected against C5, eculizimab, has already been in use in pregnant
women affected by paroxysmal nocturnal hemoglobinuria. Given
the rarity of the disease, there have only been a few reports on the
safety of this drug in pregnancy,with noobvious complications at
birth or in early childhood development (Kelly et al., 2015). The
effect of eculizimab is fortuitously confined to the maternal cir-
culation by the poor transfer of IgG2 through the placenta, and
comparison of maternal and cord blood from these pregnancies
has shown no effect on the complement system of the fetus (Hall-
stensen et al., 2015). However, with the clinical development of
small-moleculeC5aR1 inhibitors, such asCCX-168 (Woodruff et
al., 2011), it would be prudent to be cautious in the clinical use of
C5aR1-directed therapeutics during pregnancy without prior
consideration to fetal transfer and potential developmental im-
plications of C5aR1 inhibition as highlighted in this study.
This study also adds to emerging work demonstrating a wide
developmental role for complement components in mammalian
development. These include roles for complement factors in de-
velopmental processes such as radial intercalation, migration,
and synaptic pruning (Stevens et al., 2007; Carmona-Fontaine et
al., 2011; Szabo´ et al., 2016; Gorelik et al., 2017). In this context, it
is interesting to speculate what niche these proteins first filled.
The origins of the evolutionarily ancient system of complement
proteins may be as a controller of tissue organization and devel-
opment, with utilization of complement in the context of innate
immunity following later in evolution (Hawksworth et al., 2017).
In conclusion, here we show a novel role for C5aR1 as a mod-
ulator of apicobasal polarity in neural progenitor cells that is
highly conserved betweenmice and humans. Inhibition ofC5aR1
signaling during neurogenesis has deleterious consequences for
cerebral organization, resulting in behavioral abnormalities in
adultmice.Ourdata suggest that thedevelopment anduse ofC5aR1
antagonists aspotential treatments forpregnancy-related inflamma-
tory disease should be approached with extreme caution.
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